Rare Disease Day is observed every year on 28th February (or 29th in leap years)—the rarest day of the year. It is a globally coordinated movement on rare diseases, working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease.
A window into our world Rare Disease Day 2022
On behalf of all ProQRians, happy Rare Disease Day 2022. Both within ProQR and outside, we join the community in raising awareness and trying to generate change for people worldwide living with a rare disease, their families, and supporters.
Why the last day of February?
ProQR plays its part again in 2022 through three more personal interviews from ProQRians on what inspires them to work in rare disease. ProQR is a biotechnology company dedicated to changing lives by developing RNA therapies for rare genetic diseases.
Bringing ProQRians out from behind our desks and laboratory benches is a way to show the human faces behind the ground-breaking RNA science.
A window into the wide range of roles in drug development
The three videos allow ProQR to show the different parts of ProQR and what it takes to develop innovative medicines. In these series of videos, we hear from Jeroen van de Giessen, Principal Researcher, Nanyamka Braham, Director Regulatory Affairs, and Agathe Plichta, Associate Director Medical Affairs.
All three ProQRians take you through what it means to them to be part of a company trying to bring RNA therapies forward. Rare Disease Day gives us as ProQRians a chance to share what motivates us to work in rare disease.
The videos are a window into our world.
From working on new innovative compounds, understanding the complex regulatory environment, and interacting with key doctors around the world. Each part of the rich tapestry of research can be shown and celebrated.
Jeroen van de Giessen, Principal Researcher at ProQR
"I work on designing and optimizing new therapies"
Nanyamka Braham from Regulatory Affairs at ProQR
"In rare diseases patients are the experts"
Agathe Plichta, Associate Director Medical Affairs at ProQR
"Towards removing all barriers in rare diseases"